Current Oncology (Oct 2023)

Systematic Review of Nomograms Used for Predicting Pathological Complete Response in Early Breast Cancer

  • Marcelo Antonini,
  • Gabriel Duque Pannain,
  • André Mattar,
  • Odair Ferraro,
  • Reginaldo Guedes Coelho Lopes,
  • Juliana Monte Real,
  • Lucas Miyake Okumura

DOI
https://doi.org/10.3390/curroncol30100662
Journal volume & issue
Vol. 30, no. 10
pp. 9168 – 9180

Abstract

Read online

Pathological complete response (pCR) is an important surrogate outcome to assess the effects of neoadjuvant chemotherapy (NAC). Nomograms to predict pCR have been developed with local data to better select patients who are likely to benefit from NAC; however, they were never critically reviewed regarding their internal and external validity. The purpose of this systematic review was to critically appraise nomograms published in the last 20 years (2010–2022). Articles about nomograms were searched in databases, such as PubMed/MEDLINE, Embase and Cochrane. A total of 1120 hits were found, and seven studies were included for analyses. No meta-analysis could be performed due to heterogeneous reports on outcomes, including the definition of pCR and subtypes. Most nomograms were developed in Asian centers, and nonrandomized retrospective cohorts were the most common sources of data. The most common subtype included in the studies was triple negative (50%). There were articles that included HER2+ (>80%). In one study, scholars performed additional validation of the nomogram using DFS and OS as outcomes; however, there was a lack of clarity on how such endpoints were measured. Nomograms to predict pCR cannot be extrapolated to other settings due to local preferences/availability of NAC. The main gaps identified in this review are also opportunities for future nomogram research and development.

Keywords